Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M220,198Revenue $M49,605Net Margin (%)18.7Altman Z-Score2.9
Enterprise Value $M228,726EPS $1.4Operating Margin %25.9Piotroski F-Score6
P/E(ttm)24.8Beneish M-Score-2.7Pre-tax Margin (%)25.4Higher ROA y-yN
Price/Book3.310-y EBITDA Growth Rate %3.0Quick Ratio2.2Cash flow > EarningsY
Price/Sales4.65-y EBITDA Growth Rate %5.0Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow17.5y-y EBITDA Growth Rate %-14.2ROA % (ttm)5.4Higher Current Ratio y-yY
Dividend Yield %3.0PEG4.9ROE % (ttm)12.4Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M6,158ROIC % (ttm)12.1Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEKahn Brothers 2015-06-30 Reduce-0.21%$33.46 - $35.44
($34.36)
$ 35.764%Reduce 2.00%1,774,875
PFEKen Fisher 2015-06-30 Add0.04%$33.46 - $35.44
($34.36)
$ 35.764%Add 1.95%31,816,749
PFEKahn Brothers 2015-03-31 Reduce-0.39%$31.16 - $35.05
($33.51)
$ 35.767%Reduce 3.83%1,811,016
PFEJames Barrow 2015-03-31 Reduce-0.32%$31.16 - $35.05
($33.51)
$ 35.767%Reduce 12.24%55,080,222
PFENWQ Managers 2015-03-31 Reduce-0.16%$31.16 - $35.05
($33.51)
$ 35.767%Reduce 6.64%5,927,532
PFEJoel Greenblatt 2015-03-31 Add0.15%$31.16 - $35.05
($33.51)
$ 35.767%Add 38.84%1,972,788
PFECharles Brandes 2015-03-31 Reduce-0.07%$31.16 - $35.05
($33.51)
$ 35.767%Reduce 2.37%6,123,536
PFEDavid Dreman 2015-03-31 Add0.03%$31.16 - $35.05
($33.51)
$ 35.767%Add 70.38%25,202
PFEMario Gabelli 2015-03-31 Reduce-0.01%$31.16 - $35.05
($33.51)
$ 35.767%Reduce 5.80%896,431
PFEDodge & Cox 2015-03-31 Reduce-0.01%$31.16 - $35.05
($33.51)
$ 35.767%Reduce 0.89%46,776,959
PFEKen Fisher 2015-03-31 Add$31.16 - $35.05
($33.51)
$ 35.767%Add 0.04%31,208,271
PFEFirst Eagle Investment 2015-03-31 Reduce$31.16 - $35.05
($33.51)
$ 35.767%Reduce 0.12%5,266,820
PFERichard Pzena 2015-03-31 Reduce$31.16 - $35.05
($33.51)
$ 35.767%Reduce 0.50%2,159,618
PFEJohn Keeley 2015-03-31 Reduce$31.16 - $35.05
($33.51)
$ 35.767%Reduce 1.27%98,689
PFEKahn Brothers 2014-12-31 Reduce-0.49%$27.7 - $32.09
($30.23)
$ 35.7618%Reduce 5.14%1,883,217
PFEFirst Eagle Investment 2014-12-31 Add0.39%$27.7 - $32.09
($30.23)
$ 35.7618%Add 3786.85%5,272,943
PFERichard Pzena 2014-12-31 Buy 0.36%$27.7 - $32.09
($30.23)
$ 35.7618%New holding2,170,568
PFEVanguard Health Care Fund 2014-12-31 Add0.32%$27.7 - $32.09
($30.23)
$ 35.7618%Add 29.88%19,395,622
PFEMichael Price 2014-12-31 Sold Out -0.17%$27.7 - $32.09
($30.26)
$ 35.7618%Sold Out0
PFEKahn Brothers 2014-09-30 Reduce-0.59%$28.04 - $30.96
($29.58)
$ 35.7621%Reduce 6.56%1,985,161
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OLSON LAURIE JExecutive Vice President 2015-06-11Sell26,000$34.393.98view
HILL CHARLES HExecutive Vice President 2015-05-29Sell42,870$34.922.41view
SUSMAN SALLYExecutive Vice President 2015-03-12Sell46,179$345.18view
READ IAN CChairman & CEO 2015-03-05Sell67,500$34.623.29view
Dolsten MikaelPresident R&D 2015-03-05Sell58,298$34.463.77view
CANGIALOSI LORETTA VSr. Vice President, Controller 2015-02-13Sell104,000$34.732.97view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-12Sell9,000$34.852.61view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell80,200$34.234.47view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell14,800$34.34.26view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-10Sell9,000$33.785.86view

Quarterly/Annual Reports about PFE:

    News about pfe:

    Articles On GuruFocus.com
    Pfizer Increases Annual Earnings Guidance for 2015 Jul 29 2015 
    It’s Not Too Late To Buy Gilead Sciences Jul 17 2015 
    Perrigo Company Is Strong But Overvalued Jul 15 2015 
    Despite Recent Downgrade, This Ecommerce Giant is a Buy Jun 29 2015 
    Paul Tudor Jones' Top Three Stocks Deliver Positive Returns Jun 24 2015 
    Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
    A Look at James Barrow's Investment in Pfizer Jun 16 2015 
    Jim Simons' Top 3 Positions and One That Doubled Return Jun 10 2015 
    Will GlaxoSmithKline Cut Its 6% Dividend? Jun 03 2015 
    Apple, SunEdison and Biogen: Hellman, Jordan Management's Top 3 Stocks Outperform the Rise in the S& May 28 2015 

    More From Other Websites
    Bull Chart of the Day -- Pfizer Remains Healthy Jul 29 2015
    Big Pharma seeks recreational drug users for clinical trials Jul 29 2015
    Dow adds 100 points as Street awaits Fed statement; earnings eyed Jul 29 2015
    Pfizer Pulls The Plug On OTC Lipitor And It's The Patients' Fault Jul 29 2015
    Top 10 New Stocks to Trade Like Hedge Fund Renaissance Technologies Jul 29 2015
    Hospira Reports Second-Quarter 2015 Results Jul 29 2015
    The Top Drug Launches Of All Time Jul 29 2015
    Pfizer’s Dollar Dilemma Adds Pressure for Deal Making Jul 28 2015
    Pfizer (PFE) Earnings Report: Q2 2015 Conference Call Transcript Jul 28 2015
    Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal Jul 28 2015
    Gilead higher after earnings beat Jul 28 2015
    Broad rally in the market Jul 28 2015
    Pfizer Quits Over-the-Counter Lipitor Program After Trial Fails Jul 28 2015
    Edited Transcript of PFE earnings conference call or presentation 28-Jul-15 2:00pm GMT Jul 28 2015
    Pfizer chief executive has 'sufficient courage' to pursue deals Jul 28 2015
    Pfizer Eyeing Deals of Any Size in Quest to Find New Blockbuster Jul 28 2015
    Pfizer Beats Estimates On Strong Cancer Drug Sales Jul 28 2015
    Pfizer Boosts Its Earnings Outlook Jul 28 2015
    Drugmaker Pfizer tops Street 2Q forecasts, raises forecast Jul 28 2015
    Drugmaker Pfizer tops Street 2Q forecasts, raises forecast Jul 28 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    SEENSCO
    ReplySEENSCO - 1 year ago
    PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK